Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Clinical outcomes of intrauterine device insertions by newly trained providers: The ECHO trial experience.
Yacobson I, Wanga V, Ahmed K, Chipato T, Gichangi P, Kiarie J, Louw C, Morrison S, Moss M, Mugo NR, Palanee-Phillips T, Pleaner M, Scoville CW, Thomas KK, Nanda K; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Yacobson I, et al. Contracept X. 2023 Mar 30;5:100092. doi: 10.1016/j.conx.2023.100092. eCollection 2023. Contracept X. 2023. PMID: 37188149 Free PMC article.
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Lancet. 2019 Jul 27;394(10195):303-313. doi: 10.1016/S0140-6736(19)31288-7. Epub 2019 Jun 13. Lancet. 2019. PMID: 31204114 Free PMC article. Clinical Trial.
Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial.
Hofmeyr GJ, Singata-Madliki M, Batting J, Steyn P, Thomas KK, Issema R, Beesham I, Mbatsane E, Morrison C, Deese J, Smit J, Philip N, Palanee-Phillips T, Reddy K, Onono M, Mastro TD, Baeten JM; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Hofmeyr GJ, et al. PLoS One. 2024 May 9;19(5):e0299802. doi: 10.1371/journal.pone.0299802. eCollection 2024. PLoS One. 2024. PMID: 38722832 Free PMC article. Clinical Trial.
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.
Mugo NR, Stalter RM, Heffron R, Rees H, Scoville CW, Morrison C, Kourtis AP, Bukusi E, Beksinka M, Philip NM, Beesham I, Deese J, Edward V, Donnell D, Baeten JM; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Mugo NR, et al. Clin Infect Dis. 2022 Sep 10;75(4):586-595. doi: 10.1093/cid/ciab1027. Clin Infect Dis. 2022. PMID: 34910143 Free PMC article. Clinical Trial.
Age-Specific Risk Scores Do Not Improve HIV-1 Prediction Among Women in South Africa.
Peebles K, Palanee-Phillips T, Balkus JE, Beesham I, Makkan H, Deese J, Smit J, Heffron R, Morrison CS, Philip NM, Malahleha M, Kasaro M, Naidoo Y, Nielson T, Reddy K, Kotze P, Ahmed K, Rees H, Baeten JM, Barnabas RV; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Peebles K, et al. J Acquir Immune Defic Syndr. 2020 Oct 1;85(2):156-164. doi: 10.1097/QAI.0000000000002436. J Acquir Immune Defic Syndr. 2020. PMID: 32701820 Free PMC article.
Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception.
Onono M, Nanda K, Heller KB, Taylor D, Yacobson I, Heffron R, Kasaro MP, Louw CE, Nhlabasti Z, Palanee-Phillips T, Smit J, Wakhungu I, Gichangi PB, Mugo NR, Morrison C, Baeten JM; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Onono M, et al. Contracept X. 2020 May 28;2:100026. doi: 10.1016/j.conx.2020.100026. eCollection 2020. Contracept X. 2020. PMID: 32577615 Free PMC article.